DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Change in Directorate
Dr. Bruce Carter ceased to be a Director of the Company, on July 30, 2022, on account of completion of his second term as an Independent Director. DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Dr Reddys Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
Dr Reddy's Laboratories inks licensing pact with US' Slayback Pharma
Dr Reddy's Laboratories on Saturday said it has entered into a pact with US-based Slayback Pharma to acquire rights of a medication to relieve redness of the eyes DR.REDDY'S LABORATORIES LTD. - 500124 - Newspaper Publication For Unaudited Financial Results For Q1 FY23
Newspaper publication for unaudited financial results for Q1 FY23 DR.REDDY'S LABORATORIES LTD. - 500124 - Sale Of Investment In Wholly-Owned Subsidiary - Imperial Credit Private Limited
Sale of investment in wholly-owned subsidiary - Imperial Credit Private Limited DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dr. Reddy''s Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify(r) in the U.S. DR.REDDY'S LABORATORIES LTD. - 500124 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Consolidated Scrutinizer''s Report DR.REDDY'S LABORATORIES LTD. - 500124 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 38th Annual General Meeting & Voting results. DR.REDDY'S LABORATORIES LTD. - 500124 - Filing Of Form 6K For Q 1 FY23 With SEC
Filing of Form 6K for Q 1 FY23 with SEC DR.REDDY'S LABORATORIES LTD. - 500124 - Audio Recordings Of The Earnings Call Conducted On July 28, 2022.
Audio Recordings of the Earnings call conducted on July 28, 2022.